Kevin J Carroll
Overview
Explore the profile of Kevin J Carroll including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
290
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smith J, Morice A, Birring S, Parker S, Marsden P, Holcomb J, et al.
Am J Respir Crit Care Med
. 2025 Mar;
PMID: 40043304
No abstract available.
2.
Smith J, Birring S, Blaiss M, McGarvey L, Morice A, Sher M, et al.
Am J Respir Crit Care Med
. 2025 Mar;
PMID: 40043302
There is no broadly accessible treatment for patients with refractory chronic cough, a disease characterized by chronic cough that persists despite treatment for other cough-related etiologies or has no identified...
3.
Haworth C, Shteinberg M, Winthrop K, Barker A, Blasi F, Dimakou K, et al.
Lancet Respir Med
. 2024 Sep;
12(10):787-798.
PMID: 39270696
Background: Chronic lung infection with Pseudomonas aeruginosa is associated with increased exacerbations and mortality in people with bronchiectasis. The PROMIS-I and PROMIS-II trials investigated the efficacy and safety of 12-months...
4.
Sinha S, Nigwekar S, Brandenburg V, Gould L, Serena T, Moe S, et al.
EClinicalMedicine
. 2024 Sep;
75:102784.
PMID: 39252867
Background: In the CALCIPHYX trial, we investigated hexasodium fytate, an inhibitor of vascular calcification, for the treatment of calcific uraemic arteriolopathy (calciphylaxis), a rare condition characterised by painful, non-healing skin...
5.
DeVries T, Carroll K, Lewis S
Pharm Stat
. 2024 Apr;
23(5):742-762.
PMID: 38568372
In several therapeutic areas, including chronic kidney disease (CKD) and immunoglobulin A nephropathy (IgAN), there is a growing interest in how best to analyze estimated glomerular filtration rate (eGFR) data...
6.
Collins A, Carroll K, H Gerber A, Keenan E, Lerner M
Child Psychiatry Hum Dev
. 2024 Mar;
PMID: 38502300
When autistic youth are asked to assess their own social skills, they frequently rate themselves more favorably than their parents rate them. The magnitude of this informant discrepancy has been...
7.
Lewis S, Carroll K, DeVries T, Barratt J
Pharm Stat
. 2023 Nov;
23(2):276-283.
PMID: 37919258
Random coefficient (RC) models are commonly used in clinical trials to estimate the rate of change over time in longitudinal data. Trials utilizing a surrogate endpoint for accelerated approval with...
8.
Sinha S, Gould L, Nigwekar S, Serena T, Brandenburg V, Moe S, et al.
Clin Kidney J
. 2022 Jan;
15(1):136-144.
PMID: 35035944
Background: Calcific uraemic arteriolopathy (CUA; calciphylaxis) is a rare disease seen predominantly in patients receiving dialysis. Calciphylaxis is characterized by poorly healing or non-healing wounds, and is associated with mortality,...
9.
Burmeister Getz E, Carroll K, Christopher J, Morgan B, Haughie S, Cavecchi A, et al.
AAPS PharmSciTech
. 2021 Aug;
22(7):225.
PMID: 34410557
Batch-to-batch pharmacokinetic (PK) variability of orally inhaled drug products has been documented and can render single-batch PK bioequivalence (BE) studies unreliable; results from one batch may not be consistent with...
10.
Burmeister Getz E, Carroll K, Mielke J, Jones B, Benet L
AAPS PharmSciTech
. 2021 Aug;
22(7):224.
PMID: 34410534
Pharmacokinetic differences between manufacturing batches, well established for inhaled drug products, preclude control of patient risk in the customary two-way (single batch) pharmacokinetic bioequivalence crossover design if batches are randomly...